The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer

Ministry of Health, Malaysia1,600 enrolled

Overview

More recent studies have shown that the HBV-infected population has a greater risk of development of hepatocellular carcinoma. Nevertheless, there are still a significant number of people chronically infected by HBV who do not develop the complication. Hence, there exist biological markers that could be indicator for the disease-inducing and carcinogenic potential of the virus.

Study Type

OBSERVATIONAL

Enrollment

1,600

Conditions

Hepatitis B,Chronic Carcinoma,Hepatocellular

Eligibility

Sex: ALLMin age: 21 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Patients of at least 21 years old on day of giving consent for study * Patients must be able and wiling to give an informed consent * Patient with chronic HBV infection * Patient with active hepatocellular carcinoma and chronic hepatitis B * Healthy subjects Exclusion Criteria: * Patients who have co-infection with HIV or chronic hepatitis C * Subjects with other types of cancer

Locations (8)

Sultanah Bahiyah Hospital

Alor Star, Kedah, Malaysia

RECRUITING

Kuala Lumpur Hospital

Kuala Lumpur, Kuala Lumpur, Malaysia

NOT_YET_RECRUITING

Island Hospital

Pulau Pinang, Pulau Pinang, Malaysia

Central Contacts

Clinical Research Centre

CONTACT

+603-40439300 shanthini@crc.gov.my

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.